InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-7.1%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Fallon John A., Director. Director active across 4 companies, notably COLLEGIUM PHARMACEUTICAL, INC. In total, 8 disclosures have been recorded. Activity tracked since 20 May 2021. The latest transaction was filed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
9,791 shares0Common StockSEC:0001062993-25-009810:0
7,693 shares0Common StockSEC:0001062993-24-010539:0
9,792 shares0Common StockSEC:0001062993-23-011816:0
14,035 shares0Common StockSEC:0001062993-22-013301:0
2,235 shares@ US$28.870.0005% mcap50.0% of flowCommon StockSEC:0001127602-21-018010:0
2,235 shares@ US$28.8750.0% of flowCommon StockSEC:0001127602-21-018010
9,941 shares0Common StockSEC:0001192482-21-000457:0
9,941 shares0Common StockSEC:0001192482-21-000457
8 of 8 declarations
About Fallon John A.
John A. Fallon is a Director at Collegium Pharmaceutical, Inc., Insulet Corp, and Collegium Pharmaceutical, Inc. As a board member, he contributes to governance and strategic decision-making. His expertise in the healthcare sector is an asset for these companies.
